Table 2 Administration of corticosteroids, stratified by outcome
|  | All (n = 226) | Non-survivors (n = 135) | Survivors (n = 91) | p value |
|---|---|---|---|---|
Corticosteroid prescribed | ||||
 Methylprednisolone | 213 (94.2) | 132 (62.0) | 83 (38.0) | 0.0004 |
 Prednisolone | 41 (18.1) | 11 (73.2) | 30 (26.8) | 0.0007 |
 Dexamethasone | 5 (2.2) | 4 (80.0) | 1 (20.0) | 0.4470 |
Maximum dose (methylprednisolone equivalent, mg) | 80.0 (40.0–80.0) | 80.0 (40.0–80.0) | 80.0 (40.0–80.0) | 0.0821 |
Days of corticosteroid treatment | 7.0 (4.0–12.0) | 6.0 (3.0–11.0) | 9.0 (5.0–12.0) | 0.0069 |
Days of maximum dose | 3.0 (2.0–5.0) | 3.0 (1.0–5.0) | 4.0 (2.0–5.0) | 0.0287 |
Days from symptom onset to corticosteroid treatment | 13.0 (10.0–16.0) | 14.0 (11.0–18.0) | 11.0 (9.0–14.0) | 0.0031 |
Days from hospital admission to corticosteroid treatment | 1.0 (0.0–3.0) | 1.0 (0.0–4.0) | 1.0 (0.0–2.0) | 0.1892 |
Days from ARDS to corticosteroid treatment | 0.0 (0.0–2.0) | 1.0 (0.0–2.0) | 0.0 (− 1.0 to 1.0) | 0.0102 |
Days from ventilation to corticosteroid treatment | − 1.0 (− 3.0 to 0.0) | − 1.0 (− 3.0 to 0.0) | − 2.0 (− 4.0 to 1.0) | 0.7576 |